News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
663,557 Results
Type
Article (34994)
Company Profile (642)
Press Release (627920)
Multimedia
Podcasts (63)
Webinars (16)
Section
Business (198907)
Career Advice (2128)
Deals (36632)
Drug Delivery (103)
Drug Development (78422)
Employer Resources (164)
FDA (15450)
Job Trends (14724)
News (335650)
Policy (29319)
Tag
Academia (1416)
Academic (1)
Accelerated approval (10)
Adcomms (17)
Allergies (96)
Alliances (47952)
ALS (113)
Alzheimer's disease (1371)
Antibody-drug conjugate (ADC) (167)
Approvals (15442)
Artificial intelligence (307)
Autoimmune disease (36)
Automation (15)
Bankruptcy (377)
Best Places to Work (10874)
BIOSECURE Act (22)
Biosimilars (115)
Biotechnology (437)
Bladder cancer (89)
Brain cancer (30)
Breast cancer (326)
Cancer (2696)
Cardiovascular disease (209)
Career advice (1762)
Career pathing (32)
CAR-T (183)
CDC (16)
Cell therapy (506)
Cervical cancer (20)
Clinical research (65068)
Collaboration (1031)
Company closure (3)
Compensation (683)
Complete response letters (30)
COVID-19 (2238)
CRISPR (58)
C-suite (346)
Cystic fibrosis (112)
Data (2895)
Decentralized trials (2)
Denatured (4)
Depression (70)
Diabetes (316)
Diagnostics (6374)
Digital health (23)
Diversity (4)
Diversity, equity & inclusion (38)
Drug discovery (133)
Drug pricing (122)
Drug shortages (27)
Duchenne muscular dystrophy (118)
Earnings (84406)
Editorial (40)
Employer branding (24)
Employer resources (142)
Events (111428)
Executive appointments (875)
FDA (17031)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (917)
Gene editing (133)
Generative AI (27)
Gene therapy (375)
GLP-1 (798)
Government (3005)
Grass and pollen (6)
Guidances (173)
Healthcare (16004)
HIV (37)
Huntington's disease (30)
IgA nephropathy (43)
Immunology and inflammation (163)
Immuno-oncology (9)
Indications (39)
Infectious disease (2404)
Inflammatory bowel disease (147)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (120)
Interviews (425)
IPO (17307)
IRA (45)
Job creations (4258)
Job search strategy (1461)
Kidney cancer (12)
Labor market (50)
Layoffs (568)
Leadership (21)
Legal (7399)
Liver cancer (75)
Longevity (11)
Lung cancer (379)
Lymphoma (187)
Machine learning (8)
Management (58)
Manufacturing (407)
MASH (90)
Medical device (13637)
Medtech (13642)
Mergers & acquisitions (20052)
Metabolic disorders (817)
Multiple sclerosis (99)
NASH (18)
Neurodegenerative disease (124)
Neuropsychiatric disorders (37)
Neuroscience (2067)
NextGen: Class of 2025 (6003)
Non-profit (1944)
Now hiring (48)
Obesity (420)
Opinion (262)
Ovarian cancer (93)
Pain (111)
Pancreatic cancer (119)
Parkinson's disease (186)
Partnered (21)
Patents (304)
Patient recruitment (164)
Peanut (52)
People (57367)
Pharmaceutical (132)
Pharmacy benefit managers (20)
Phase I (20457)
Phase II (29019)
Phase III (21518)
Pipeline (1637)
Policy (189)
Postmarket research (1980)
Preclinical (8366)
Press Release (64)
Prostate cancer (136)
Psychedelics (40)
Radiopharmaceuticals (270)
Rare diseases (468)
Real estate (5825)
Recruiting (66)
Regulatory (21246)
Reports (39)
Research institute (1393)
Resumes & cover letters (331)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (94)
Series A (165)
Series B (118)
Service/supplier (26)
Sickle cell disease (61)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (25)
Startups (3906)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (62)
The Weekly (58)
Vaccines (730)
Venture capital (57)
Weight loss (264)
Women's health (33)
Worklife (19)
Date
Today (70)
Last 7 days (372)
Last 30 days (1872)
Last 365 days (31217)
2025 (16809)
2024 (35657)
2023 (40397)
2022 (50857)
2021 (54255)
2020 (51171)
2019 (42186)
2018 (32196)
2017 (32691)
2016 (31000)
2015 (36542)
2014 (29348)
2013 (24271)
2012 (25884)
2011 (26112)
2010 (23924)
Location
Africa (684)
Alabama (69)
Alaska (6)
Arizona (173)
Arkansas (11)
Asia (42803)
Australia (6831)
California (7491)
Canada (2336)
China (700)
Colorado (320)
Connecticut (326)
Delaware (182)
Europe (89977)
Florida (1068)
Georgia (244)
Hawaii (2)
Idaho (56)
Illinois (554)
India (29)
Indiana (371)
Iowa (18)
Japan (227)
Kansas (105)
Kentucky (29)
Louisiana (13)
Maine (68)
Maryland (903)
Massachusetts (5744)
Michigan (259)
Minnesota (452)
Mississippi (3)
Missouri (88)
Montana (30)
Nebraska (22)
Nevada (75)
New Hampshire (69)
New Jersey (2098)
New Mexico (30)
New York (2064)
North Carolina (1169)
North Dakota (8)
Northern California (3284)
Ohio (220)
Oklahoma (12)
Oregon (40)
Pennsylvania (1577)
Puerto Rico (17)
Rhode Island (38)
South America (1078)
South Carolina (34)
South Dakota (1)
Southern California (2730)
Tennessee (98)
Texas (1105)
United States (27488)
Utah (211)
Virginia (183)
Washington D.C. (68)
Washington State (648)
West Virginia (4)
Wisconsin (67)
663,557 Results for "sumitomo chemical company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sumitomo Pharma America Announces that Nuvisertib (TP-3654) Has Received FDA Fast Track Designation for the Treatment of Myelofibrosis
June 13, 2025
·
5 min read
BioMidwest
Sumitomo Chemical and Valent BioSciences Announce Divestiture of Pace International and Future Collaboration with AgroFresh Solutions in the Postharvest Solutions Space
Sumitomo Chemical Co., Ltd. and Valent BioSciences LLC announced that Pace International LLC and its operations overseas will become part of AgroFresh Solutions, Inc., a well-established leader in the postharvest solutions space.
March 27, 2024
·
5 min read
Press Releases
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
June 30, 2025
·
8 min read
Press Releases
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
December 2, 2024
·
6 min read
Press Releases
Sumitomo Pharma America Presents New Data on Vibegron at the 2025 American Urological Association Annual Meeting
April 30, 2025
·
7 min read
Business
Ginkgo Bioworks and Sumitomo Chemical Announce Expanded Partnership To Develop Functional Chemicals with Synthetic Biology
Sumitomo Chemical Co., Ltd and Ginkgo Bioworks today announced a new program to develop functional chemicals with synthetic biology and expand upon the companies’ existing biomanufacturing partnership.
July 18, 2023
·
6 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Genetown
Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials
Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene and its polymer, poly p-hydroxystyrene, using a combination of biosynthesis, chemosynthesis, and polymerization.
August 1, 2023
·
3 min read
Business
RevolKa Ltd.: Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform is pleased to announce the successful completion of the collaborative drug discovery project with Sumitomo Pharma Co., Ltd. for rare diseases within the contractually agreed time frame.
June 23, 2023
·
3 min read
Business
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Sumitomo Mitsui Banking Corporation announced that the three companies signed a master agreement on April 22, 2024, to establish a joint venture company.
April 22, 2024
·
5 min read
1 of 66,356
Next
